MCRB icon

Seres Therapeutics

78 hedge funds and large institutions have $274M invested in Seres Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
22
Reduced
22
Closed
13
Calls
$408K
Puts
$144K
Net Calls
+$264K
Net Calls Change
-$414K
Name Holding Trade Value Shares
Change
Shares
Change %
MCM
76
Manchester Capital Management
Vermont
$1K +$1K +8 New
Capital World Investors
77
Capital World Investors
California
-$6.08M -41,391 Closed
Jennison Associates
78
Jennison Associates
New York
-$1.54M -10,510 Closed
O
79
OrbiMed
New York
-$699K -4,761 Closed
VEA
80
Virtus ETF Advisers
New York
-$563K -3,836 Closed
AA
81
ALPS Advisors
Colorado
-$399K -2,718 Closed
ARTA
82
A.R.T. Advisors
New York
-$337K -2,298 Closed
ACI
83
AMP Capital Investors
Australia
-$179K -1,206 Closed
CS
84
Credit Suisse
Switzerland
-$103K -704 Closed
Russell Investments Group
85
Russell Investments Group
United Kingdom
-$85K -580 Closed
VF
86
Virtu Financial
New York
-$78K -533 Closed
Group One Trading
87
Group One Trading
Illinois
-$15K -101 Closed
KF
88
Krilogy Financial
Missouri
-$3K -20 Closed
US Bancorp
89
US Bancorp
Minnesota
-$1K -6 Closed